TVM CAPITAL LIFE SCIENCE
TVM Capital Life Science is a dedicated life science venture capital firm, with offices in Montreal, Canada and Munich, Germany. Since inception, TVM Capital Life Science has invested in entrepreneurial venture backed companies. Over several fund generations, their investment strategy has included a multi-stage investment approach spanning discovery to market ready companies as well as profitable companies searching for growth capital. Their investment focus has always been broad and includes investments in therapeutics, technology platforms, medtech and diagnostics. They invest in Canada, the U.S., Germany and Western Europe with their dedicated team of investment professionals based in Montreal and Munich.
TVM CAPITAL LIFE SCIENCE
Industry:
Finance Financial Services Health Care Venture Capital
Founded:
1983-01-01
Status:
Active
Contact:
+49899989920
Email Addresses:
[email protected]
Technology used in webpage:
IPv6 Person Schema Gravatar Profiles GoDaddy DNS GoDaddy GoDaddy Email Host Europe DomainFACTORY
Similar Organizations
MassMutual Ventures
MMV is a multi-stage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health.
New Enterprise Associates
New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
Current Employees Featured
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-01-19 | ImmunoRx Pharma | ImmunoRx Pharma acquired by TVM Capital Life Science | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-04-22 | Smart Reporting | TVM Capital Life Science investment in Series C - Smart Reporting | 23 M EUR |
| 2024-02-05 | Vektor Medical | TVM Capital Life Science investment in Series A - Vektor Medical | 16 M USD |
| 2024-01-31 | Myo | TVM Capital Life Science investment in Series A - Myo | 8 M EUR |
| 2023-02-01 | Recurv Pharma | TVM Capital Life Science investment in Venture Round - Recurv Pharma | 24 M USD |
| 2022-03-03 | Egg Medical | TVM Capital Life Science investment in Venture Round - Egg Medical | 13 M USD |
| 2022-02-01 | Centogene | TVM Capital Life Science investment in Post-IPO Equity - Centogene | 15 M EUR |
| 2021-03-03 | Access Vascular | TVM Capital Life Science investment in Series B - Access Vascular | 20 M USD |
| 2021-02-12 | Kent Imaging | TVM Capital Life Science investment in Venture Round - Kent Imaging | 15 M USD |
| 2021-02-01 | Vespina Lifesciences | TVM Capital Life Science investment in Venture Round - Vespina Lifesciences | N/A |
| 2020-04-16 | leon nanodrugs | TVM Capital Life Science investment in Series B - leon nanodrugs | N/A |
More informations about "TVM Capital Life Science"
About us - TVM Capital Life Science Venture Capital
TVM Capital Life Science was born out of venture capital firm Techno Venture Management, which was launched in 1983 and has focused exclusively on what we know best – Life …See details»
Strategy & Approach - TVM Capital Life Science …
Our long successful track record supports our approach of investing in lasting partnerships with life science companies, not just providing capital. With TVM LSI I and TVM LSI II, TVM continues to build a portfolio of differentiated first-in …See details»
TVM Capital Life Science - Crunchbase
TVM Capital Life Science may be growing as it has led a €23 million Series C financing round for a medical reporting technology company and co-led a $16 million Series A financing round for …See details»
TVM Capital Life Science - Investments, Portfolio & Company Exits
Jan 19, 2021 TVM Capital Life Science 's most notable exits include Centogene, Acer Therapeutics, and CoLucid Pharmaceuticals. TVM Capital Life Science has acquired …See details»
TVM Capital Life Science Announces Substantially
Oct 27, 2020 TVM Capital Life Science: Stefan Fischer, Managing Partner (Finance), ... Organization Profile. TVM Capital Life Science. Contact Cision. 866-245-2317 from 8 AM - 10 PM ET Contact UsSee details»
TVM Capital - Crunchbase Investor Profile & Investments
TVM Capital Healthcare also announced a USD 35 million investment into Boston Oncology Arabia. Learn more. Investment Thesis . Overview. TVM Capital invests in early to late-stage biotechnology, pharmaceutical, and healthcare …See details»
TVM Capital Life Science Leads €23 Million Series C Financing …
Apr 22, 2024 MUNICH, Germany and MONTREAL, April 22, 2024 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on …See details»
TVM Capital Life Sciences | BDC.ca
TVM Capital Life Sciences is a fund whose mission is to invest in the development of life science products and the growth of companies in the pharmaceutical, biopharmaceutical, medical technology and healthcare …See details»
TVM Capital Life Science - EU-Startups
TVM Capital Life Science is a dedicated life science venture capital firm, with offices in Montreal, Canada and Munich, Germany. Since inception, TVM Capital Life Science has invested in …See details»
TVM Capital Life Science closes Fund VII at $202 mln
Oct 6, 2014 TVM Capital Life Science, a global venture capital firm with an office in Montréal, has closed its TVM Life Science Ventures VlI. Focusing on achieving human clinical proof-of …See details»
Team Archive - TVM Capital Life Science Venture Capital
Jan 26, 2024 At TVM Capital Life Science, he focuses on evaluation of deal opportunities and investment management for therapeutics. He also works closely with the firm’s strategic …See details»
TVM News Archives - TVM Capital Life Science Venture Capital
Oct 30, 2024 Munich, Germany and Montreal, Quebec, Canada, February 6, 2024 – TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on …See details»
Home - TVM Capital Healthcare
TVM Capital Healthcare is a highly specialized healthcare expansion and growth capital investment firm operating out of offices in Dubai and Singapore. We invest equity capital into …See details»
TVM Capital Life Science - Funding, Financials, Valuation & Investors
TVM Capital Life Science has raised a total of $729.6M across 4 funds, their latest being TVM Life Science Innovation II. This fund was announced on Oct 27, 2020 and raised a total of . …See details»
TVM Capital Life Science Announces Promotions to Recognize …
Feb 23, 2023 MONTREAL, Canada and MUNICH, Germany, Feb. 23, 2023 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading international venture capital firm …See details»
News & Events - TVM Capital Life Science Venture Capital
TVM Capital Life Science will take part in the 24th Annual Biotech in Europe Forum September 25-26, 2024 in Basel, Switzerland at the Mövenpick Hotel. Basel, Switzerland at the …See details»
TVM Capital Life Science - Updates, News, Events, Signals & Triggers
TVM Capital Life Science is a dedicated life science venture capital firm, with offices in Montreal, Canada and Munich, Germany. Search Crunchbase Start Free TrialSee details»
Life sciences M&A, divestments and restructuring - Deloitte
Oct 24, 2024 Over the past five years, M&A activity has rebounded strongly, driven in part by a step-up in investor activism. M&A has become a critical element in the corporate strategy of …See details»
Portfolios Archive - TVM Capital Life Science Venture Capital
“TVM incorporates teamwork into its culture of working with biotech companies, creating a strong framework for successful collaboration.” Michael Salzmann, PhD, CEO, AL-S Pharma “TVM …See details»
TVM Capital Life Science - Contacts, Employees, Board
TVM Capital Life Science is a dedicated life science venture capital firm, with offices in Montreal, Canada and Munich, Germany. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»